Soleno Therapeutics announces pricing of $138M public offering
Seeking Alpha News (Fri, 3-May 2:42 AM ET)
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
Globe Newswire (Thu, 2-May 10:32 PM ET)
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
Globe Newswire (Thu, 2-May 4:01 PM ET)
Globe Newswire (Tue, 30-Apr 8:00 AM ET)
Globe Newswire (Mon, 29-Apr 8:00 AM ET)
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Fri, 19-Apr 4:05 PM ET)
Globe Newswire (Wed, 6-Mar 4:05 PM ET)
Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
Globe Newswire (Thu, 22-Feb 8:00 AM ET)
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
Soleno Therapeutics trades on the NASDAQ stock market under the symbol SLNO.
As of May 8, 2024, SLNO stock price declined to $45.92 with 11,020 million shares trading.
SLNO has a beta of 0.43, meaning it tends to be less sensitive to market movements. SLNO has a correlation of 0.00 to the broad based SPY ETF.
SLNO has a market cap of $1.67 billion. This is considered a Small Cap stock.
In the last 3 years, SLNO stock traded as high as $53.82 and as low as $.85.
The top ETF exchange traded funds that SLNO belongs to (by Net Assets): XBI, VTI, DWAS, VXF, LABU.
SLNO has outperformed the market in the last year with a price return of +1083.5% while the SPY ETF gained +26.8%. However, in the short term, SLNO had mixed performance relative to the market. It has underperformed in the last 3 months, returning -1.4% vs +4.0% return in SPY. But in the last 2 weeks, SLNO shares have fared better than the market returning +14.4% compared to SPY +2.1%.
SLNO support price is $44.58 and resistance is $49.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLNO stock will trade within this expected range on the day.